Notice of results
Download full announcement
Renalytix AI plc (AIM: RENX), a developer of artificial intelligence clinical in vitro diagnostics for kidney disease, announces that it will release its preliminary results for the year ended 30 June 2019 on Tuesday, 3 September 2019.
Analyst briefing
An analyst briefing will take place at 1pm on Tuesday, 3 September 2019. If you would like to register, please contact Walbrook PR on 020 7933 8780 or email renalytix@walbrookpr.com
Investor briefing
A briefing open to all investors will take place on Tuesday, 3 September 2019 at the Brand Exchange, 3 Birchin Lane, London EC3V 9BW from 5.15pm for a 5.30pm start and will be followed by light refreshments. If you would like to register, please contact Walbrook PR on 020 7933 8780 or email renalytix@walbrookpr.com
Enquiries
| Renalytix AI plc | www.renalytixai.com |
| James McCullough, CEO | Via Walbrook PR or Tel: +1 646 397 3970 |
| Stifel (Nominated Adviser & Joint Broker) | Tel: 020 7710 7600 |
|
Alex Price / Jonathan Senior / Ben Maddison (Investment Banking) |
|
| N+1 Singer (Nominated Adviser & Broker) | Tel: 020 7496 3000 |
| Aubrey Powell / James White / George Tzimas (Corporate Finance) Tom Salvesen / Mia Gardner (Corporate Broking) |
|
| Walbrook PR Limited | Tel: 020 7933 8780 renalytix@walbrookpr.com |
| Paul McManus Lianne Cawthorne |
Mob: 07980 541 893 07584 391 303 |